StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Cumulative participant enrollment across by Quarter

Cumulative participant enrollment across interventional clinical trials (participants)

QuarterlyAnnual

Moderna Cumulative participant enrollment across: 469,580.00 participants in Q2 2026, up 20.0% from a year earlier. That is the highest of the 34 quarters on record here.

Latest, Q2 2026
469,580.00
Period ended Jun 30, 2026
Change on a year earlier
+20.0%
391,288.00 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
1
ClinicalTrials.gov API v2 (ModernaTX, Inc.)

Where the Q2 2026 figure comes from

Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCumulative participant enrollment across interventional clinical trials (participants)Year on yearSource
Q2 2026Jun 30, 2026469,580.00+20.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2026Mar 31, 2026468,338.00+19.8%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2025Dec 31, 2025464,168.00+19.2%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2025Sep 30, 2025392,832.00+45.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2025Jun 30, 2025391,288.00+105.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2025Mar 31, 2025390,948.00+106.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2024Dec 31, 2024389,278.00+105.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2024Sep 30, 2024270,934.00+51.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2024Jun 30, 2024190,190.00+11.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2024Mar 31, 2024189,655.00+18.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2023Dec 31, 2023189,381.00+30.5%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2023Sep 30, 2023178,590.00+24.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2023Jun 30, 2023171,229.00+42.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2023Mar 31, 2023160,224.00+48.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2022Dec 31, 2022145,128.00+39.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2022Sep 30, 2022143,643.00+146.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Breakdown

What makes up cumulative participant enrollment across

Cite this data

StockData. (2026). Moderna Cumulative participant enrollment across, quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-enrollment

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.